Dr Reddy's Laboratories Monday said German regulatory authority has completed the follow-on audit of Duvvada manufacturing facility in Visakhapatnam and the EU-GMP certification of the plant remains active excluding for one new product.
"On November 9, 2018, the Regulatory Authority of Germany (Regierung von Oberbayem) concluded the follow-on audit of our formulations manufacturing facility in Duvvada, Visakhapatnam," Dr Reddy's Labs said in a BSE filing.
The facility is considered compliant and the EU-GMP certification continues to remain active with one specific exclusion of a new product, it added.
"The company will be submitting a detailed corrective and preventive action plan (CAPA) to the authorities," it said.
Shares of Dr Reddy's Labs were trading at Rs 2,415.40 per scrip on BSE, up 0.36 per cent from the previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app